Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Expected use of approximately $25 million in first quarter of 2025 intended to preserve approximately 200,000 ADSs held as treasury shares ...

Equals 5, the leading AdTech platform revolutionizing pharmaceutical and healthcare marketing is excited to announce a strategic growth equity investment from Baleon Capital. This investment marks a ...

Samsung Biologics (KRX: 207940.KS), a global contract manufacturing and development organization (CDMO), today announced that ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...

Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential Commercialization SOUTH SAN FRANCISCO ...

State-of-the-art transactional repository (rTH): the fully GS1-compliant central hub will securely manage all supply chain ...

As political ad creators, we can take away some key lessons from this year’s lineup of Super Bowl ads. Here are four that ...

Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the ...